WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 8 fonti

FDA Approves Eli Lilly’s Weight Loss Pill Foundayo—Fewer Food And Drink Restrictions

Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.

Raccontata daforbes.comcnbc.comft.comupi.comusatoday.comwired.comilpost.itwired.it

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
forbes.comStai leggendo1 mesi fa

FDA Approves Eli Lilly’s Weight Loss Pill Foundayo—Fewer Food And Drink Restrictions

Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.

originale

Timeline cronologica

  1. mercoledì 1 aprile 2026·forbes.com

    FDA Approves Eli Lilly’s Weight Loss Pill Foundayo—Fewer Food And Drink Restrictions

    Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.

  2. mercoledì 1 aprile 2026·cnbc.com

    FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

    The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

usatoday.com
1 mesi fa

Eli Lilly wins approval for new weight-loss pill. What to know.

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

Leggi questa versione → originale
upi.com1 mesi fa

FDA approves Eli Lilly's GLP-1 weight-loss pill Foundayo - UPI.com

The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.

Leggi questa versione → originale
cnbc.com1 mesi fa

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

Leggi questa versione → originale
wired.com1 mesi fa

FDA Approves Eli Lilly’s GLP-1 Pill

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

Leggi questa versione → originale
wired.it1 mesi fa

Come funziona Foundayo, il nuovo farmaco dimagrante in pillole appena approvato negli Stati Uniti

Prodotto dalla casa farmaceutica Eli Lilly, la compressa fa parte dei medicinali anti-obesità Glp-1, la stessa categoria di Ozempic e Wegovy

Leggi questa versione → originale
  • mercoledì 1 aprile 2026·ft.com

    Eli Lilly wins US approval for weight-loss drug in pill form

    New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs

  • mercoledì 1 aprile 2026·upi.com

    FDA approves Eli Lilly's GLP-1 weight-loss pill Foundayo - UPI.com

    The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.

  • mercoledì 1 aprile 2026·usatoday.com

    Eli Lilly wins approval for new weight-loss pill. What to know.

    Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

  • mercoledì 1 aprile 2026·wired.com

    FDA Approves Eli Lilly’s GLP-1 Pill

    Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

  • giovedì 2 aprile 2026·ilpost.it

    Negli Stati Uniti è stato approvato un farmaco dimagrante di Eli Lilly sotto forma di pillola

    Dopo aver eseguito alcuni test, Eli Lilly ha detto che Foundayo permette di perdere circa il 12-15 per cento del peso corporeo: è meno di quanto permetta la versione iniettabile…

  • giovedì 2 aprile 2026·cnbc.com

    Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

    Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.

  • giovedì 2 aprile 2026·wired.it

    Come funziona Foundayo, il nuovo farmaco dimagrante in pillole appena approvato negli Stati Uniti

    Prodotto dalla casa farmaceutica Eli Lilly, la compressa fa parte dei medicinali anti-obesità Glp-1, la stessa categoria di Ozempic e Wegovy